T1	intervention 11 46	preoperative lymphatic chemotherapy
T2	total-participants 383 388	Sixty
T3	eligibility 403 433	breast cancer of stages II-III
T4	intervention-participants 473 478	Forty
T5	control-participants 617 623	Twenty
T6	control 640 647	control
T7	outcome 968 983	apoptotic index
T10	outcome 1180 1216	expression of Bcl-2 and Bax proteins
T11	outcome 1323 1341	ratio of Bcl-2/Bax
T8	iv-cont-mean 1103 1106	9.5
T13	iv-cont-sd 1109 1112	2.7
T9	cv-cont-mean 1120 1123	3.8
T14	cv-cont-sd 1126 1129	1.4
